See also this year's filing and all EDGAR filings for this company.
PDF Report 0001534120_2023_Avalo_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001534120, Avalo Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,416,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 14,409,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 2,542,000 |
| 4 | LiabilitiesCurrent | 22,114,000 |
| 5 | LiabilitiesNoncurrent | 1,711,000 |
| 6 | remainder_Liabilities | 20,457,000 |
| 7 | CostOfGoodsAndServicesSold | 3,434,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,711,000 |
| 9 | ResearchAndDevelopmentExpense | 31,308,000 |
| 10 | remainder_Expenses | 66,000 |
| 11 | remainder_Revenues | 18,051,000 |
| 12 | remainder_NetIncome | -4,190,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 33,367,000 |
| 1 | Liabilities | 44,282,000 |
| 2 | Expenses | 55,519,000 |
| 3 | Revenues | 18,051,000 |
| 4 | StockholdersEquity | -10,915,000 |
| 5 | NetIncome | -41,658,000 |
| 6 | ComprehensiveNetIncome | -41,658,000 |
| 7 | BaseVar | 77,704,500 |
| 8 | EconomicCapitalRatio | -1.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
